HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis

被引:177
作者
Stokkers, PCF [1 ]
Reitsma, PH [1 ]
Tytgat, GNJ [1 ]
van Deventer, SJH [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Lab Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands
关键词
ulcerative colitis; Crohn's disease; HLA-DR; HLA-DQ;
D O I
10.1136/gut.45.3.395
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background-Susceptibility to inflammatory bowel disease (IBD) is partially genetically determined and the HLA class II genes are candidates for a role in genetic susceptibility to IBD, because their products play a central role in the immune response. Multiple studies have reported associations between HLA-DR or -DQ phenotypes and either ulcerative colitis or Crohn's disease, but much of the data are still controversial. Aims-To estimate overall associations between HLA class II phenotypes and IBD, and to establish the relative risk conferred by HLA-DR and -DQ phenotypes by meta-analysis, Methods-Medline was searched for publications reporting on the relation between IBD and HLA class II phenotypes. Raw data were extracted by recalculating the number of phenotypes or the number of alleles of the main antigens. Odds ratios and confidence intervals were calculated according to the Mantel-Haenszel method. Results-DR2, DR9, and DRB1*0103 were positively associated with ulcerative colitis, and a negative association was found for DR4 and ulcerative colitis. For Crohn's disease a positive association was found with DR7, DRB3(star)0301, and DQ4 and a negative association with DR2 and DR3. Conclusions-Both ulcerative colitis and Crohn's disease are associated with specific HLA class II phenotypes. Further analysis of these phenotypes and subgroup analysis may elucidate how these alleles contribute to susceptibility to IBD.
引用
收藏
页码:395 / 401
页数:7
相关论文
共 48 条
  • [1] ASAKURA H, 1982, GASTROENTEROLOGY, V82, P413
  • [2] Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD)
    Bouma, G
    Pool, MO
    Crusius, JBA
    Schreuder, GMT
    Hellemans, HPR
    Meijer, BUGA
    Kostense, PJ
    Giphart, MJ
    Meuwissen, SGM
    Pena, AS
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (01) : 175 - 179
  • [3] HLA-DRB1*03, but not the TNFA-308 promoter gene polymorphism, confers protection against fistulising Crohn's disease
    Bouma, G
    Poen, AC
    García-González, MA
    Schreuder, GMT
    Felt-Bersma, RJF
    Meuwissen, SGM
    Peña, AS
    [J]. IMMUNOGENETICS, 1998, 47 (06) : 451 - 455
  • [4] American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12
    Brant, SR
    Fu, YF
    Fields, CT
    Baltazar, R
    Ravenhill, G
    Pickles, MR
    Rohal, PM
    Mann, J
    Kirschner, BS
    Jabs, EW
    Bayless, TM
    Hanauer, SB
    Cho, JH
    [J]. GASTROENTEROLOGY, 1998, 115 (05) : 1056 - 1061
  • [5] 3-DIMENSIONAL STRUCTURE OF THE HUMAN CLASS-II HISTOCOMPATIBILITY ANTIGEN HLA-DR1
    BROWN, JH
    JARDETZKY, TS
    GORGA, JC
    STERN, LJ
    URBAN, RG
    STROMINGER, JL
    WILEY, DC
    [J]. NATURE, 1993, 364 (6432) : 33 - 39
  • [6] Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease
    Cariappa, A
    Sands, B
    Forcione, D
    Finkelstein, D
    Podolsky, DK
    Pillai, S
    [J]. GUT, 1998, 43 (02) : 210 - 215
  • [7] CARUSO C, 1983, TISSUE ANTIGENS, V21, P170
  • [8] CARUSO C, 1985, TISSUE ANTIGENS, V25, P47
  • [9] Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1q, 3q, and 4q:: Evidence for epistasis between 1p and IBD1
    Cho, JH
    Nicolae, DL
    Gold, LH
    Fields, CT
    LaBuda, MC
    Rohal, PM
    Pickles, MR
    Qin, L
    Fu, YF
    Mann, JS
    Kirschner, BS
    Jabs, EW
    Weber, J
    Hanauer, SB
    Bayless, TM
    Brant, SR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (13) : 7502 - 7507
  • [10] Positive and negative associations of distinct HLA-DR2 subtypes with ulcerative colitis (UC)
    Concha, EGD
    FernandezArquero, M
    SantaCruz, S
    LopezNava, G
    Figueredo, MA
    DiazRubio, M
    GarciaParedes, J
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 108 (03) : 392 - 395